K213919: Dexcom G7 Continuous Glucose Monitoring System (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K213919 (Dexcom G7 Continuous Glucose Monitoring System, cleared 2022-12-07 for Dexcom, Inc.) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K213919 |
| Cleared Device Trade / Generic Name | Dexcom G7 Continuous Glucose Monitoring System |
| FDA Applicant on Filing | Dexcom, Inc. |
| FDA 3-Letter Product Classification | Product Code QBJ |
| FDA Substantial Equivalence Decision Date | 2022-12-07 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Dexcom across sibling Meru public-data platforms.
Inspect consolidated manufacturer lineage at Dexcom, Inc., compare peer devices under FDA Product Code QBJ, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.